Best VCs for Therapeutics
319 venture capitalists actively investing in Therapeutics.
Partner
Khosla Ventures
Alex invests where computation, biology, and healthcare converge. His scientific and clinical background supports a systems view of biomarker discovery, therapeutics, diagnostics, personalized medicin
Chief Operating Officer
Newton Biocapital
Danny Gonnissen is listed in a Chief Operating Officer capacity at Newton Biocapital. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distin
Co-founder and Managing Partner
Bioqube Ventures
Nico Vandervelpen is listed by Bioqube Ventures as Co-founder and Managing Partner. The profile is aligned to the firm's published thesis: Invests across stages and helps build therapeutics companies
Partner
Bioqube Ventures
Roderick Verhelst is listed by Bioqube Ventures as Partner. The profile is aligned to the firm's published thesis: Invests across stages and helps build therapeutics companies from inception through e
Investor Relations Director
BioGeneration Ventures
The official roster identifies Rachelle Young as Investor Relations Director. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.
Senior Associate ESG and Impact
BioGeneration Ventures
The official roster identifies Elisa Camorani as Senior Associate ESG and Impact. This profile applies BioGeneration Ventures's published strategy and does not infer undisclosed personal signing autho
Managing Partner
V-Bio Ventures
The official roster identifies Willem Broekaert as Managing Partner. This profile applies V-Bio Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower in
Venture Partner
BioGeneration Ventures
The official roster identifies Arnoud Dijkstra as Venture Partner. This profile applies BioGeneration Ventures's published strategy and does not infer undisclosed personal signing authority or a narro
Chief Compliance Officer & Legal Affairs
BioGeneration Ventures
The official roster identifies Machteld Groeneveld as Chief Compliance Officer & Legal Affairs. This is a fund team or operating role; no direct investment mandate or personal signing authority is inf
Managing Partner
BioGeneration Ventures
The official roster identifies Oskar Slotboom as Managing Partner. This profile applies BioGeneration Ventures's published strategy and does not infer undisclosed personal signing authority or a narro
General Partner
BioGeneration Ventures
The official roster identifies Daniela Couto as General Partner. This profile applies BioGeneration Ventures's published strategy and does not infer undisclosed personal signing authority or a narrowe
Manager Secretarial Services
BioGeneration Ventures
The official roster identifies Olga Ziessen as Manager Secretarial Services. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.
Head of Investor Relations
BioGeneration Ventures
The official roster identifies Robbert van de Griendt as Head of Investor Relations. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.
Venture Partner
BioGeneration Ventures
The official roster identifies Wouter Verhoeven as Venture Partner. This profile applies BioGeneration Ventures's published strategy and does not infer undisclosed personal signing authority or a narr
Principal
BioGeneration Ventures
The official roster identifies Rianne Ellenbroek as Principal. This profile applies BioGeneration Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower
Senior Advisor
BioGeneration Ventures
The official roster identifies John J.P. Kastelein as Senior Advisor. This profile applies BioGeneration Ventures's published strategy and does not infer undisclosed personal signing authority or a na
AML/KYC Manager
BioGeneration Ventures
The official roster identifies Patricia Vonk as AML/KYC Manager. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.
Vice President Finance
BioGeneration Ventures
The official roster identifies Jennifer Fritzsche as Vice President Finance. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.
Head of Impact and ESG
BioGeneration Ventures
The official roster identifies Silva Dezelan as Head of Impact and ESG. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.
Associate
BioGeneration Ventures
The official roster identifies Karen Chan as Associate. This profile applies BioGeneration Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individ
Executive Assistant
BioGeneration Ventures
The official roster identifies Dragana Dragusin as Executive Assistant. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.
Venture Partner
BioGeneration Ventures
The official roster identifies Elena Ritsou as Venture Partner. This profile applies BioGeneration Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower
Paralegal
BioGeneration Ventures
The official roster identifies Maureen Wouters as Paralegal. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.
Venture Partner
BioGeneration Ventures
The official roster identifies Rob de Ree as Venture Partner. This profile applies BioGeneration Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower i
Managing Partner
V-Bio Ventures
The official roster identifies Christina Takke as Managing Partner. This profile applies V-Bio Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower ind
Partner
V-Bio Ventures
The official roster identifies Katja Rosenkranz as Partner. This profile applies V-Bio Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual
Finance Manager
V-Bio Ventures
The official roster identifies Martin Solleveld as Finance Manager. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.
Venture Partner
V-Bio Ventures
The official roster identifies Mathias Falcenberg as Venture Partner. This profile applies V-Bio Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower i
Managing Partner
V-Bio Ventures
The official roster identifies Shelley Margetson as Managing Partner. This profile applies V-Bio Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower i
Partner
V-Bio Ventures
The official roster identifies Ward Capoen as Partner. This profile applies V-Bio Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual manda
Vice President Finance | Funds
BioGeneration Ventures
The official roster identifies Cyril Lesser as Vice President Finance | Funds. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.
Partner, Diagnostics
Kurma Partners
The official roster identifies Benjamin Belot as Partner, Diagnostics. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority or a narrower
Managing Partner, Biofund
Kurma Partners
The official roster identifies Rémi Droller as Managing Partner, Biofund. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority or a narrow
Partner, Biofund
Kurma Partners
The official roster identifies Amanda Gett as Partner, Biofund. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority or a narrower individ
Partner, Diagnostics
Kurma Partners
The official roster identifies Alain Horvais as Partner, Diagnostics. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority or a narrower i
Managing Partner, Biofund
Kurma Partners
The official roster identifies Thierry Laugel as Managing Partner, Biofund. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority or a narr
Partner Germany, Biofund
Kurma Partners
The official roster identifies Peter Neubeck as Partner Germany, Biofund. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority or a narrow
Partner Germany, Growth Opportunities
Kurma Partners
The official roster identifies Daniel Parera as Partner Germany, Growth Opportunities. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authorit
Partner, Diagnostics
Kurma Partners
The official roster identifies Philippe Peltier as Partner, Diagnostics. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority or a narrowe
Partner, Growth Opportunities
Kurma Partners
The official roster identifies Jean-François Rivassou as Partner, Growth Opportunities. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authori
Partner, Biofund
Kurma Partners
The official roster identifies Hadrien Bouchez as Partner, Biofund. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority or a narrower ind
Associate, Diagnostics
Kurma Partners
The official roster identifies Laura Achach as Associate, Diagnostics. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority or a narrower
Associate, Diagnostics
Kurma Partners
The official roster identifies Samantha Zennou as Associate, Diagnostics. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority or a narrow
Associate, Biofund
Kurma Partners
The official roster identifies Florence de Coorebyter as Associate, Biofund. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority or a nar
Associate, Biofund
Kurma Partners
The official roster identifies Anna Tchorzewska as Associate, Biofund. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority or a narrower
Associate, Growth Opportunities
Kurma Partners
The official roster identifies Maylis Deschamps as Associate, Growth Opportunities. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority o
Analyst, Diagnostics
Kurma Partners
The official roster identifies Louise-Marie Rakotoarison as Analyst, Diagnostics. This profile applies Kurma Partners's published strategy and does not infer undisclosed personal signing authority or
Secretary General, Head of Compliance & Legal
Kurma Partners
The official roster identifies Muriel Domine as Secretary General, Head of Compliance & Legal. This is a fund team or operating role; no direct investment mandate or personal signing authority is infe
Financial Director
Kurma Partners
The official roster identifies Cyril Bedran as Financial Director. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.
Senior Financial Controller
Kurma Partners
The official roster identifies Sonny Guilhem as Senior Financial Controller. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.
Financial Controller
Kurma Partners
The official roster identifies Ornella Gomis as Financial Controller. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.
Office Manager
Kurma Partners
The official roster identifies Steffi Minga as Office Manager. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.
Management Assistant
Kurma Partners
The official roster identifies Fatima Boubnad as Management Assistant. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.
Managing Partner BFF I
Bioqube Ventures
Dirk Reyn is listed by Bioqube Ventures as Managing Partner BFF I. The profile is aligned to the firm's published thesis: Invests across stages and helps build therapeutics companies from inception th
Finance Director
Bioqube Ventures
Geert Tackaert is listed by Bioqube Ventures as Finance Director. The profile is aligned to the firm's published thesis: Invests across stages and helps build therapeutics companies from inception thr
Principal
Bioqube Ventures
Alexander Demoulin is listed by Bioqube Ventures as Principal. The profile is aligned to the firm's published thesis: Invests across stages and helps build therapeutics companies from inception throug
Venture Partner
Bioqube Ventures
Bonnie van Wilgenburg is listed by Bioqube Ventures as Venture Partner. The profile is aligned to the firm's published thesis: Invests across stages and helps build therapeutics companies from incepti
Principal
Bioqube Ventures
Clément Salque is listed by Bioqube Ventures as Principal. The profile is aligned to the firm's published thesis: Invests across stages and helps build therapeutics companies from inception through ea
Co-founder and Managing Partner
Bioqube Ventures
Debora Dumont is listed by Bioqube Ventures as Co-founder and Managing Partner. The profile is aligned to the firm's published thesis: Invests across stages and helps build therapeutics companies from
Senior Advisor
Bioqube Ventures
Janine Schuurman is listed by Bioqube Ventures as Senior Advisor. The profile is aligned to the firm's published thesis: Invests across stages and helps build therapeutics companies from inception thr
Entrepreneur In Residence
Bioqube Ventures
Joris De Maeyer is listed by Bioqube Ventures as Entrepreneur In Residence. The profile is aligned to the firm's published thesis: Invests across stages and helps build therapeutics companies from inc
Partner and CSO
Bioqube Ventures
Joris Vanderlocht is listed by Bioqube Ventures as Partner and CSO. The profile is aligned to the firm's published thesis: Invests across stages and helps build therapeutics companies from inception t
Chief Regulatory and Development Officer
Newton Biocapital
Michihiko Wada is listed in a Chief Regulatory and Development Officer capacity at Newton Biocapital. The firm does not publish a person-specific investment thesis for this role; the profile preserves
Partner IR & BD
Bioqube Ventures
Odile Rundquist is listed by Bioqube Ventures as Partner IR & BD. The profile is aligned to the firm's published thesis: Invests across stages and helps build therapeutics companies from inception thr
Senior Advisor
Bioqube Ventures
Sandy Zweifach is listed by Bioqube Ventures as Senior Advisor. The profile is aligned to the firm's published thesis: Invests across stages and helps build therapeutics companies from inception throu
Senior Executive Assistant & Office Manager
Bioqube Ventures
Sylvie Schrijvers is listed by Bioqube Ventures as Senior Executive Assistant & Office Manager. The profile is aligned to the firm's published thesis: Invests across stages and helps build therapeutic
Chief Operating Officer
Bioqube Ventures
Tessa Ceyssens is listed by Bioqube Ventures as Chief Operating Officer. The profile is aligned to the firm's published thesis: Invests across stages and helps build therapeutics companies from incept
Executive Partner
Bioqube Ventures
Tom Heyman is listed by Bioqube Ventures as Executive Partner. The profile is aligned to the firm's published thesis: Invests across stages and helps build therapeutics companies from inception throug
Managing Partner
Vesalius Biocapital
Gaston Matthyssens, PhD invests or supports investments through Vesalius Biocapital's published strategy: Build a concentrated European life-sciences portfolio across therapeutics, diagnostics, medica
Managing Partner
Vesalius Biocapital
Alain Parthoens invests or supports investments through Vesalius Biocapital's published strategy: Build a concentrated European life-sciences portfolio across therapeutics, diagnostics, medical device
Managing Partner
Vesalius Biocapital
Christian Schneider, PhD invests or supports investments through Vesalius Biocapital's published strategy: Build a concentrated European life-sciences portfolio across therapeutics, diagnostics, medic
Managing Partner
Vesalius Biocapital
Stephane Verdood invests or supports investments through Vesalius Biocapital's published strategy: Build a concentrated European life-sciences portfolio across therapeutics, diagnostics, medical devic
Partner
Vesalius Biocapital
Guy Geldhof invests or supports investments through Vesalius Biocapital's published strategy: Build a concentrated European life-sciences portfolio across therapeutics, diagnostics, medical devices an
Managing Partner
Wellington Partners
Dr. Rainer Strohmenger invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics
Managing Partner
Wellington Partners
Dr. Johannes Fischer invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics,
Partner
Wellington Partners
Dr. Varun Gupta invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics, medic
Managing Partner, CFO
Wellington Partners
Harald Keller is listed in a Managing Partner, CFO capacity at Wellington Partners. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinct
Managing Partner, Legal Counsel
Wellington Partners
Ernst Mannheimer is listed in a Managing Partner, Legal Counsel capacity at Wellington Partners. The firm does not publish a person-specific investment thesis for this role; the profile preserves the
Partner
Wellington Partners
Sabine Kannegiesser invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics, m
Manager
Wellington Partners
Dr. Lisa Gartenmann invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics, m
Associate
Wellington Partners
Dr. Robert Buschauer invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics,
Office Manager
Wellington Partners
Karina Schuster is listed in a Office Manager capacity at Wellington Partners. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction a
Sustainability Manager
Wellington Partners
Ulrike Spring is listed in a Sustainability Manager capacity at Wellington Partners. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinc
Finance Manager
Wellington Partners
Cornelia Huber is listed in a Finance Manager capacity at Wellington Partners. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction a
Finance Manager
Wellington Partners
Karin Juen is listed in a Finance Manager capacity at Wellington Partners. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and u
Finance Manager
Wellington Partners
Anja Weibel is listed in a Finance Manager capacity at Wellington Partners. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and
Finance Manager
Wellington Partners
Olena Ionkina is listed in a Finance Manager capacity at Wellington Partners. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction an
Project Manager
Wellington Partners
Doris Gowik invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics, medical d
Venture Advisor
Wellington Partners
Dr. Regina Hodits is listed in a Venture Advisor capacity at Wellington Partners. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinctio
Venture Partner
Wellington Partners
Prof. Dr. Erich Schlick invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutic
Venture Partner
Wellington Partners
Dr. Ulrich Granzer invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics, me
Venture Partner
Wellington Partners
Dr. Mel Spigelman invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics, med
Venture Partner
Wellington Partners
Dr. Wolfgang Baiker invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics, m
Venture Partner
Wellington Partners
Stuart Essig, Ph.D. invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics, m
Venture Partner
Wellington Partners
Dr. Bo Jesper Hansen invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics,
Venture Partner
Wellington Partners
Dr. Peter Hirth invests or supports investments through Wellington Partners's published strategy: Back European life-sciences entrepreneurs from early development through growth in therapeutics, medic
Chief Executive Officer
Newton Biocapital
Alain Parthoens is listed in a Chief Executive Officer capacity at Newton Biocapital. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distin
Japan Representative
Newton Biocapital
Sadashi Suzuki is listed in a Japan Representative capacity at Newton Biocapital. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinctio
Chief Medical and Regulatory Officer
Newton Biocapital
Guy Heynen is listed in a Chief Medical and Regulatory Officer capacity at Newton Biocapital. The firm does not publish a person-specific investment thesis for this role; the profile preserves the rol
Venture Director
Newton Biocapital
Pierre Detrixhe invests or supports investments through Newton Biocapital's published strategy: Invest in private life-sciences companies in Europe and Japan whose products address important unmet med